The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

ResMed

  • RMD
  • NYSE
  • Consumer Products
  • Latest 46.58
  • Currency US$
  • Change -0.27
  • Percent Change -0.576 %
  • Volume 328,864
  • Wed Apr 16, 2014 11:26 AM EDT NYSE data delayed 15 minutes.
  • Open 47.25
  • Previous Close 46.85
  • High 47.39
  • Low 46.555
  • Bidx2 46.55
  • Askx1 46.58
  • 52-week High10/22 57.34
  • 52-week Low02/03 41.52
  • Beta 0.68
  • Market Cap 6,618.09M
  • EPS 2.24
  • P/E 20.795
  • Forward P/E 17.16
  • PEG 1.33
  • Annual Dividend 1.00
  • Yield 2.147

News

Financials & Calendars

Income Statement

  • Sales $1,540,190,000
  • Earnings $325,490,000
  • Return on Equity 19.54%

Cash Flow

  • Cash Flow --
  • Cash $972,670,000
  • Current Ratio 6.44

12 months ended Dec 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $2,345,580,000
  • Liabilities $706,630,000
  • Liabilities-to-Equity Ratio 0.43

Price Ratios

  • Price to Sales 4.29
  • Price to Book 4.03
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Jan 23 $0.63 Apr 23 $0.63
Surprises Jan 23 -4.76% n/a n/a
Dividends Feb 14 $0.25 n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 16, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

ResMed Inc. is a leading designer, manufacturer and distributor of medical equipment for treating and diagnosing sleep disordered breathing. Sleep disordered breathing includes sleep apnea and related respiratory conditions. The company sells a comprehensive range of diagnostic and treatment devices in countries through a combination of wholly owned subsidiaries and independent distributors.

Related Securities
Symbol Type Latest % Chg

Officers

  • Peter C. Farrell Executive chairman
  • Michael J. Farrell Chief executive officer and di
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

9001 SPECTRUM CENTER BLVD.
SAN DIEGO, CA
92123

Phone: (858)-746-2400
Fax: (858)-8365501

investorrelations@resmed.com
www.resmed.com

Ideas & Discussion

Live Discussion of RMD on StockTwits